Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. | |
Related Subjects: |Emergency Drugs |Emergency Drug Antidotes |Emergency Cardiac Drugs |Emergency Endocrine Drugs |Emergency Gastrointestinal Drugs |Emergency Haematology Drugs |Emergency Neuropsychiatric drugs |Emergency Pain drugs |Emergency Respiratory drugs |Emergency Obstetric and Gynaecology Drugs |Emergency Paediatric Drugs
๐งช MOA: Replenishes glutathione stores, serves as a glutathione substitute, and enhances sulfate conjugation of acetaminophen (paracetamol).
๐ Dose IV: 150 mg/kg in 200 mL D5W over 1 hr, then 50 mg/kg in 500 mL D5W over 4 hrs, then 100 mg/kg in 1 L D5W over 16 hrs (21 total hrs; may need continuous LFTs and APAP level until liver enzymes normalise).
๐ Dose PO: 140 mg/kg ร1, then 70 mg/kg every 4h ร17 doses (72 hrs total).
๐ฏ Indication: Paracetamol overdose.
โ ๏ธ Notes: Hypersensitivity reactions (consider switching to PO or slowing infusion). Can occur with PO. Pregnancy B.
๐งช MOA: Acts on A1 receptors in AV node, causing transient AV block.
๐ Dose IV: 6 mg rapid IV push; if no effect, 12 mg IV every 2 min ร2.
๐ฏ Indication: Stable SVT / stable narrowโcomplex tachycardia.
โ ๏ธ Notes: Avoid in preโexisting 2nd/3rdโdegree AV block without pacing; can be proโarrhythmic. Pregnancy C.
๐งช MOA: Selective ฮฒ2โagonist.
๐จ Dose Neb: 2.5โ5 mg every 20 min for 1st hour, then 2.5โ10 mg every 1โ4 hrs PRN (alt: 10โ15 mg over 1 hr).
๐ฏ Indication: Acute bronchospasm; hyperkalaemia.
โ ๏ธ Notes: Hypokalaemia, tachycardia, hyperglycaemia. Pregnancy C.
๐งช MOA: Class III (Kโบ efflux blocker) with Class I/II/IV effects.
๐ Dose IV: Pulseless VF/VT: 300 mg IV push, then 150 mg IV push if needed. Stable wideโcomplex tachy: 150 mg IV over 10 min, then 1 mg/min ร6 hrs, then 0.5 mg/min.
๐ฏ Indication: Pulseless VT/VF; wideโcomplex tachyarrhythmias.
โ ๏ธ Notes: Hypotension; proโarrhythmic risk. Pregnancy D.
๐งช MOA: Antimuscarinic (anticholinergic).
๐ Dose IV: OP/carbamate toxicity: 1โ6 mg every 3โ5 min PRN until secretions stop. Bradycardia (adult): 0.5 mg every 3โ5 min (max 3 mg).
๐ฏ Indication: OP/carbamate poisoning; bradycardia.
โ ๏ธ Notes: Avoid in hyperthermia and tachyarrhythmias. Pregnancy C.
๐งช MOA: Increases serum calcium; stabilises cardiac myocytes.
๐ Dose IV: 10% solution (1 g per 10 mL).
๐ฏ Indication: Hyperkalaemia; hypocalcaemia with dysrhythmia.
โ ๏ธ Notes: CaCl more potent than gluconate; CaCl peripherally โ severe phlebitis (prefer CVC). Pregnancy C.
๐งช MOA: Enhances GABAergic inhibition.
๐ Dose IV/IM: 2โ10 mg every 6h PRN. ๐ PO: 2โ10 mg every 6h PRN.
๐ฏ Indication: Seizure abortion; alcohol withdrawal; agitation; muscle spasm.
โ ๏ธ Notes: Respiratory depression; hypotension. Pregnancy D.
๐งช MOA: NonโDHP Caยฒโบ channel blocker; slows AV conduction.
๐ Dose IV: 0.25 mg/kg once; may repeat 0.35 mg/kg after 15 min; infusion 5โ15 mg/hr.
๐ฏ Indication: AF with RVR; stable SVT.
โ ๏ธ Notes: Hypotension; bradycardia. Pregnancy C.
๐งช MOA: ฮฒ1 > ฮฒ2 agonist.
๐ Dose IV: 2โ20 mcg/kg/min.
๐ฏ Indication: Decompensated HF; refractory hypotension.
โ ๏ธ Notes: Tachycardia; hypotension if hypovolaemic; PVCs. Pregnancy B.
๐งช MOA: ฮฑ1, ฮฒ1, dopaminergic agonist (dose dependent).
๐ Dose IV: <5 mcg/kg/min = dopaminergic; 5โ10 = ฮฒ; 10โ20 = ฮฑ.
๐ฏ Indication: Decompensated HF; hypotension.
โ ๏ธ Notes: Tachyarrhythmias; tissue necrosis if extravasation (prefer CVC). Pregnancy C.
๐งช MOA: Dopamine antagonist / ฮฑโantagonist.
๐ Dose IV: 1.25โ2.5 mg every 4h PRN.
๐ฏ Indication: Antiemetic; migraine abortion.
โ ๏ธ Notes: QT prolongation (torsades risk); NMS; EPS. Pregnancy C.
๐งช MOA: ฮฑ/ฮฒ agonist.
๐ Dose: ACLS: 1 mg 1:10,000 IV (PALS: 0.01 mg/kg). Anaphylaxis: 0.1โ0.5 mg 1:1,000 IM. Hypotension: 1โ10 mcg/min IV.
๐ฏ Indication: Anaphylaxis; cardiac arrest algorithms; severe asthma.
โ ๏ธ Notes: Dosing errors; tissue necrosis; arrhythmias. Pregnancy C.
๐งช MOA: Potentiates ATIII; inhibits Xa > IIa.
๐ Dose SQ: 1 mg/kg every 12h or 1.5 mg/kg every 24h.
๐ฏ Indication: PE; NSTEMI; unstable angina.
โ ๏ธ Notes: Monitor antiโXa if renal impairment/obesity; neuraxial procedures contraindicated. Pregnancy B.
๐งช MOA: Selective ฮฒ1โblocker.
๐ Dose IV: 500 mcg/kg load; 50โ300 mcg/kg/min infusion.
๐ฏ Indication: Aortic dissection.
โ ๏ธ Notes: May precipitate CHF; hypotension; bronchospasm. Pregnancy C.
๐งช MOA: PPI (Hโบ/Kโบ ATPase inhibitor).
๐ Dose IV: 80 mg bolus then 8 mg/hr infusion.
๐ฏ Indication: Nonโvariceal upper GI bleed.
โ ๏ธ Notes: Generally well tolerated acutely. Pregnancy B.
๐งช MOA: GABAโmimetic hypnosis.
๐ Dose IV: 0.3 mg/kg.
๐ฏ Indication: RSI induction.
โ ๏ธ Notes: Possible adrenal suppression; lowers seizure threshold. Pregnancy C.
๐งช MOA: Opioid ฮผโagonist.
๐ Dose IV: 25โ100 mcg every 1โ2h (~1 mcg/kg).
๐ฏ Indication: Analgesia; sedation adjunct.
โ ๏ธ Notes: Respiratory depression; hypotension (vasodilation); laryngospasm. Pregnancy C.
๐งช MOA: Alcohol dehydrogenase inhibitor.
๐ Dose IV: 15 mg/kg load; then 10 mg/kg every 12h ร4; then 15 mg/kg every 12h until EG <20 mg/dL and asymptomatic with normal pH.
๐ฏ Indication: Methanol / ethylene glycol toxicity.
โ ๏ธ Notes: Generally safe. Pregnancy C.
๐งช MOA: Voltageโgated Naโบ channel stabiliser.
๐ Dose IV: 15โ20 mg/kg load at 150 mg/min.
๐ฏ Indication: Status epilepticus.
โ ๏ธ Notes: Rapid admin โ hypotension/arrhythmias; cardiac monitoring required. Pregnancy D.
๐งช MOA: Loop diuretic (Naโบ/Clโป reabsorption inhibition).
๐ Dose IV: 20โ40 mg initially; reassess; up to 200 mg single dose.
๐ฏ Indication: Pulmonary oedema; CHF exacerbation; hyperkalaemia (if diuresis).
โ ๏ธ Notes: Volume depletion; hypokalaemia; metabolic alkalosis; ototoxicity. Pregnancy C.
๐งช MOA: โcAMP independent of ฮฒโreceptor; gluconeogenesis & glycogenolysis.
๐ Dose IV/IM/SQ: ฮฒโblocker/CCB tox: 3โ10 mg load then 1โ10 mg/hr. Hypoglycaemia: 1 mg.
๐ฏ Indication: ฮฒโblocker or CCB toxicity; hypoglycaemia.
โ ๏ธ Notes: Anaphylactoid reactions; hypotension; emesis (aspiration risk). Pregnancy B.
๐งช MOA: Dopamine (D1/D2) antagonist.
๐ Dose PO/IM/IV: 5โ10 mg every 2h (max 100 mg/day). Elderly: start 1 mg IM.
๐ฏ Indication: Agitation; psychosis.
โ ๏ธ Notes: Dementiaโpsychosis warning; NMS/EPS; QT prolongation. Pregnancy C.
๐งช MOA: Potentiates ATIII; inhibits thrombin and factors IX, X, XI, XII.
๐ Dose IV: VTE: 80 u/kg bolus then 18 u/kg/hr. ACS/AF: 60 u/kg bolus then 12 u/kg/hr.
๐ฏ Indication: VTE; ACS (LMWH preferred in NSTEMI).
โ ๏ธ Notes: Bleeding risk; protamine reverses. Pregnancy C.
๐งช MOA: Glucocorticoid/mineralocorticoid effects.
๐ Dose IV: Adrenal crisis: 100 mg bolus then 50 mg every 6h ร24h then taper. Septic shock: 50 mg every 6h. Status asthmaticus: 1โ2 mg/kg every 6h ร24h then maintenance.
๐ฏ Indication: Adrenal insufficiency; severe asthma; vasopressorโrefractory shock.
โ ๏ธ Notes: Immunosuppression; hyperglycaemia. Pregnancy C.
๐งช MOA: Opioid ฮผโagonist.
๐ Dose IV: 1โ2 mg every 3โ6h.
๐ฏ Indication: Analgesia.
โ ๏ธ Notes: Respiratory depression; hypotension. 1 mg IV โ 7 mg IV morphine. Pregnancy C.
๐งช MOA: โPeripheral glucose uptake; shifts Kโบ intracellularly.
๐ Dose IV: HyperK: 5โ10 units once. CCB OD: 1 u/kg bolus + 25 g dextrose if BG <250; then 0.1โ1 u/kg/hr with dextrose to maintain BG 100โ200 mg/dL. DKA/HHS: 0.1 u/kg bolus + 0.1 u/kg/hr infusion.
๐ฏ Indication: Hyperkalaemia; CCB overdose; DKA/HHS.
โ ๏ธ Notes: Hypokalaemia; hypoglycaemia. Only regular insulin IV. Pregnancy B.
๐งช MOA: NMDA receptor antagonist.
๐ Dose IV: Analgesia (subโdissociative): 0.1โ0.5 mg/kg. Procedural: 0.5โ1 mg/kg. RSI: 2 mg/kg.
๐ฏ Indication: Analgesia; procedural sedation; RSI induction.
โ ๏ธ Notes: Emergence reactions (treat with benzo); laryngospasm; โIOP/โICP; tachycardia; hypertension. Pregnancy D.
๐งช MOA: ฮฑ1/ฮฒ1/ฮฒ2 antagonist.
๐ Dose IV: Bolus 20โ80 mg every 10 min PRN; infusion 1โ8 mg/min.
๐ฏ Indication: Hypertensive emergency.
โ ๏ธ Notes: CHF exacerbation; bradycardia; bronchospasm. Pregnancy C.
๐งช MOA: Enhances GABAergic inhibition.
๐ Dose IV: Bolus 1โ2 mg; infusion 1โ10 mg/hr.
๐ฏ Indication: Delirium tremens; status epilepticus; serotonin syndrome; agitation.
โ ๏ธ Notes: Respiratory depression; hypotension. Pregnancy D.
๐งช MOA: Modulates neuromuscular and cardiac excitability.
๐ Dose IV: Eclampsia: 2โ4 g over 5 min. Torsades: 2 g push. Asthma: 2 g over 15 min.
๐ฏ Indication: Torsades/ventricular arrhythmias; status asthmaticus; eclampsia.
โ ๏ธ Notes: Hypotension; respiratory depression. Pregnancy A.
๐งช MOA: Osmotic diuretic.
๐ Dose IV: 1 g/kg once.
๐ฏ Indication: Elevated ICP; impending herniation.
โ ๏ธ Notes: Dehydration risk; osmotic nephrosis.
๐งช MOA: Ultraโshortโacting barbiturate (sedation/hypnosis).
๐ Dose IV: 1 mg/kg, then 0.5 mg/kg every 2โ5 min PRN.
๐ฏ Indication: Procedural sedation.
โ ๏ธ Notes: Laryngospasm (treat with more methohexital); respiratory depression; hypotension. Pregnancy B.
๐งช MOA: Glucocorticoid/mineralocorticoid effects.
๐ Dose IV: Asthma: 1 mg/kg. Allergy: 1 mg/kg. PCP PNA: 30 mg IV BID ร5 days then taper.
๐ฏ Indication: Severe asthma; PCP pneumonia with Aโa gradient >35 or PaO2 <70; acute hypersensitivity reaction.
โ ๏ธ Notes: Immunosuppression; hyperglycaemia. Pregnancy C.
๐งช MOA: Dopamine antagonist in chemoreceptor trigger zone.
๐ Dose IV: 10 mg every 6h PRN.
๐ฏ Indication: Vomiting prevention and treatment.
โ ๏ธ Notes: Tardive dyskinesia/EPS; dystonia; methaemoglobinaemia. Pregnancy B.
๐งช MOA: Benzodiazepine; GABA potentiation.
๐ Dose IV: RSI: 0.1 mg/kg. Infusion: 1โ10 mg/hr. Procedural: 0.02โ0.04 mg/kg.
๐ฏ Indication: Seizure abortion; procedural/ventilator sedation; RSI.
โ ๏ธ Notes: Respiratory depression; hypotension. Pregnancy D.
๐งช MOA: Opioid ฮผโagonist.
๐ Dose IV: 2โ10 mg every 2โ6h (~0.1 mg/kg).
๐ฏ Indication: Analgesia.
โ ๏ธ Notes: Respiratory depression; hypotension (vasodilation). Pregnancy C.
๐งช MOA: Dihydropyridine Caยฒโบ blocker selective for cerebral arteries.
๐ Dose PO: 60 mg every 4h.
๐ฏ Indication: Subarachnoid haemorrhage.
โ ๏ธ Notes: Hypotension (minimised by selectivity). Pregnancy C.
๐งช MOA: Venodilator; โcGMP.
๐ Dose IV: 5โ200 mcg/min; increase by 10 mcg every 3โ5 min to effect (often higher for pulmonary oedema).
๐ฏ Indication: CHF; angina.
โ ๏ธ Notes: Hypotension; methaemoglobinaemia. Pregnancy C.
๐งช MOA: Direct vasodilator; NO donor.
๐ Dose IV: Start 0.3 mcg/kg/min; titrate to effect; max 10 mcg/kg/min.
๐ฏ Indication: Hypertensive emergency.
โ ๏ธ Notes: Cyanide toxicity; methaemoglobinaemia; hypotension. Pregnancy C.
๐งช MOA: ฮฑ1 > ฮฒ1 agonist.
๐ Dose IV: 1โ30 mcg/min.
๐ฏ Indication: Hypotension refractory to IV fluids.
โ ๏ธ Notes: Tachyarrhythmias; tissue necrosis if extravasation (prefer CVC). Pregnancy C.
๐งช MOA: Splanchnic vasoconstriction; โ portal pressure.
๐ Dose IV/SQ: Variceal bleed: 50 mcg IV bolus, then 50 mcg/hr infusion. Sulfonylurea tox: 50 mcg SQ every 6h PRN.
๐ฏ Indication: Bleeding oesophageal varices; sulfonylurea toxicity.
โ ๏ธ Notes: May precipitate biliary disease. Pregnancy B.
๐งช MOA: Antagonist at dopamine, histamine, ฮฑ1, and 5โHT2 receptors.
๐ Dose IM: 5โ10 mg/day (max 30 mg/day). ๐ ODT: 5โ10 mg/day (max 30 mg/day).
๐ฏ Indication: Agitation; psychosis.
โ ๏ธ Notes: Not for dementiaโrelated psychosis; NMS/EPS; orthostatic hypotension; QT prolongation; no IV form. Pregnancy C.
๐งช MOA: 5โHT3 receptor antagonist (central).
๐ Dose IV: 4โ8 mg every 4โ6h PRN.
๐ฏ Indication: Nausea/vomiting prevention and treatment.
โ ๏ธ Notes: QT prolongation; torsades (rare). Pregnancy B.
๐งช MOA: Barbiturate causing sedation/hypnosis.
๐ Dose IV: 20 mg/kg once; may repeat 5โ10 mg/kg in 20 min (max 30 mg/kg). Max infusion 50 mg/min.
๐ฏ Indication: Status epilepticus.
โ ๏ธ Notes: Respiratory depression; hypotension. Pregnancy D.
๐งช MOA: Various glucocorticoid/mineralocorticoid effects.
๐ Dose PO: 1 mg/kg/day (usual 5โ60 mg based on response).
๐ฏ Indication: Asthma exacerbation; PCP pneumonia (Aโa >35 or PaO2 <70); allergic reaction.
โ ๏ธ Notes: Immunosuppression; GI ulcer/perforation; hyperglycaemia. Pregnancy C.
๐งช MOA: GABAA agonist; Naโบ channel blocker.
๐ Dose IV: Procedural: 1 mg/kg bolus, then 0.5 mg/kg every 3 min; RSI: 1.5โ2.5 mg/kg; Vent sedation: 5โ50 mcg/kg/min.
๐ฏ Indication: Procedural sedation; RSI induction; ventilator sedation.
โ ๏ธ Notes: Hypotension; anaphylaxis; bradycardia; apnoea. Pregnancy B.
๐งช MOA: Ionically binds heparin.
๐ Dose IV: 1 mg neutralises 100 u heparin (max 50 mg) at 5 mg/min.
๐ฏ Indication: Heparinโinduced bleeding.
โ ๏ธ Notes: Anaphylaxis (history of prior use/fish allergy); rapid infusion โ hypotension. Pregnancy C.
๐งช MOA: Nonโdepolarisng neuromuscular blocker.
๐ Dose IV: 1 mg/kg.
๐ฏ Indication: RSI paralysis.
โ ๏ธ Notes: Prolonged paralysis. Pregnancy B.
๐งช MOA: Increases serum bicarbonate; increases buffer stores.
๐ Dose IV: HyperK/metabolic acidosis: 50 mEq once. TCA OD: 1โ2 mEq/kg bolus. Salicylate tox: 3 amps (150 mEq) in 1 L D5W; bolus then infusion to maintain urine pH 7.5โ8.
๐ฏ Indication: Hyperkalaemia; TCA toxicity; salicylate toxicity; metabolic acidosis.
โ ๏ธ Notes: Caution in CHF; risk of metabolic alkalosis/hypernatraemia. Pregnancy C.
๐งช MOA: Depolarising neuromuscular blocker.
๐ Dose: 1.5 mg/kg IV (or 3โ4 mg/kg IM).
๐ฏ Indication: RSI paralysis.
โ ๏ธ Notes: Hyperkalaemia risk; subacute burn/crush injury (โK); glaucoma (โIOP); โICP. Pregnancy C.